15 June 2021	AH: Heidelberg Pharma AG to Raise Capital in a Private Placement	PDF	Read More
18 May 2021	PM: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions	PDF	Read More
29 April 2021	PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021	PDF	Read More
31 March 2021	PR: Heidelberg Pharma to Present New Data on its Proprietary ATAC Technology Platform at the AACR Annual Meeting 2021	PDF	Read More
25 March 2021	PR: Heidelberg Pharma announces financial figures for fiscal year 2020 and provides business update	PDF	Read More
19 March 2021	AH: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini	PDF	Read More
01 March 2021	PR: Heidelberg Pharma Expands Management Team	PDF	Read More
11 February 2021	PR: Heidelberg Pharma and Indiana University Publish Results on HER2-ATAC for Targeted Immunotherapy of Triple Negative Breast Cancer in Science Translational Medicine	PDF	Read More
04 February 2021	AH: FDA Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101	PDF	Read More
21 December 2020	AH: Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment	PDF	Read More
12 November 2020	PR: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets	PDF	Read More
05 November 2020	PR: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020	PDF	Read More
08 October 2020	PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020	PDF	Read More
29 September 2020	AH: Heidelberg Pharma AG Announces Adjustment of Guidance	PDF	Read More
14 September 2020	PR: Heidelberg Pharma Receives Milestone Payment from Partner Magenta	PDF	Read More
10 September 2020	PR: Heidelberg Pharma Announces Participation at Various Conferences	PDF	Read More
22 July 2020	PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions	PDF	Read More
21 July 2020	AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline	PDF	Read More
09 July 2020	PR: Heidelberg Pharma reports on first half-year 2020	PDF	Read More
24 June 2020	PR: Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020	PDF	Read More
27 April 2020	AH: Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program	PDF	Read More
27 April 2020	AH: Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement	PDF	Read More
23 April 2020	PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020	PDF	Read More
31 March 2020	PR: Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy	PDF	Read More
26 March 2020	PR: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal	PDF	Read More
19 March 2020	PR: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update	PDF	Read More
04 March 2020	PR: Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion	PDF	Read More
24 February 2020	PR: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index	PDF	Read More
22 January 2020	AH: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini	PDF	Read More
21 November 2019	AH: Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement	PDF	Read More

Press Releases and Ad-hoc Announcements